CVRx, Inc. (CVRX) vs Edesa Biotech, Inc. (EDSA)

A side-by-side comparison of CVRx, Inc. and Edesa Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CVRX vs EDSA

growth of $100 · dividends reinvested · last 5y
CVRX -94.4% (-43.9%/yr)EDSA -89.6% (-36.4%/yr)EDSA compounded faster over this window
050100150Start $10020222023202420252026$6$10
CVRX EDSA

CVRX vs EDSA: by the numbers

  • •CVRX is the larger company ($43M vs $37M market cap).
  • •Both run net losses; EDSA's is the smaller (0.00% vs -84.93% net margin).

Metrics side by side

Valuation

MetricCVRXEDSA
P/S ratio0.71N/A
P/B ratio2.1792.71

Profitability

MetricCVRXEDSA
Gross margin86.60%0.00%
Operating margin-90.49%0.00%
Net margin-84.93%0.00%
ROE-260.45%-160.05%
ROIC-59.93%-166.02%

Growth (annualized)

MetricCVRXEDSA
Revenue CAGR (5Y)46.51%N/A
Total return CAGR (5Y)-37.86%-39.88%

Frequently asked

How have CVRX and EDSA total returns compared?
Over the past 5 years, CVRX delivered -37.86% and EDSA delivered -39.88% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.